-
Mashup Score: 2Stephen Liu, MD, on Key Debates in NSCLC - 16 day(s) ago
Read the full article here
Tweet
-
Mashup Score: 6Do Disparities in Minimally-Invasive Surgery Access Influence Mortality in Early-Stage NSCLC? | Docwire News - 16 day(s) ago
Read the full article here
Tweet-
📋 Do disparities in access to minimally invasive surgery influence mortality in patients with early-stage NSCLC? 📰 A recent study by a team from @SmidtHeart addressed the question. ➡️ Learn more: https://t.co/aTJ8Z6uRUr #NSCLC #lcsm #LungCancer https://t.co/hBEturpkCZ
-
-
Mashup Score: 1
Read the full article here
Tweet-
🫁 The @RadiologyACR has announced that its Lung Cancer Screening Registry is expanding and will evolve into the Early Lung Cancer Detection Registry later this year. ➡️ Learn more: https://t.co/WiYbz21LKO #lcsm #LungCancer #SCLC #NSCLC https://t.co/QJK7x6rNxr
-
-
Mashup Score: 0CROWN 5-Year Subgroup Analysis Shows PFS Is Consistent With Overall Patient Population - 16 day(s) ago
Read the full article here
Tweet-
📋 The 5-year follow-up from the subgroup of Asian patients in the CROWN study was recently published in @JTOonline, showing that the PFS remains unreached in this subgroup. ➡️ Learn more: https://t.co/8NEQVI0ViH #lcsm #NSCLC https://t.co/gJfUMjVcAw
-
-
Mashup Score: 2HARMONi-2 Interim Analysis: Ivonescimab Shows PFS Improvements Over Pembrolizumab in NSCLC - 16 day(s) ago
Read the full article here
Tweet-
🫁 Ivonescimab significantly improved PFS compared with pembrolizumab in patients with previously untreated advanced PD-L1–positive NSCLC, according to HARMONi-2 results published today in @TheLancet. ➡️ Learn more: https://t.co/j2Pe58DSfu #lcsm #LungCancer #NSCLC https://t.co/hnPcKHPpSr
-
🗨️ What are some of the most pressing questions in lung cancer? 💡 In this new interview, @StephenVLiu of @Georgetown, @LombardiCancer, shares his insights & discusses the research needed to address these questions. ➡️ Watch: https://t.co/El9WVYFDCQ #NSCLC #lcsm #lungcancer https://t.co/GdJIkqIxxY